e-Drug3D 104 |
CHLOROTRIANISENE DISCONTINUED
|
cas 569-57-3 |
CLASS GENITO |
ROUTE (list) ORAL |
ATC code |
PK parameters |
Target - |
DrugCentral Estrogen receptor beta UNIPROT Q92731 ESR2 |
Download SDF file | 1-[2-chloro-1,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene Formula: Calculated chemical properties: MW 380.85 NB_atoms 27 XLogP 5.87 PSA 33.364 NB_HD 0 NB_HA 3 fsp3 0.13 Lipinski(0=no;1=yes) 0 |
FDA NDA 008102 (pdf not found) INN (CHLOROTRIANISENE) TACE (SANOFI AVENTIS US) APPROVAL= - YEAR= 0 DISCONTINUED NDA 011444 (pdf not found) INN (CHLOROTRIANISENE) TACE (SANOFI AVENTIS US) APPROVAL= - YEAR= 0 DISCONTINUED NDA 016235 (pdf not found) INN (CHLOROTRIANISENE) TACE (SANOFI AVENTIS US) APPROVAL= - YEAR= 0 DISCONTINUED NDA 084652 (pdf not found) INN (CHLOROTRIANISENE) CHLOROTRIANISENE (BANNER PHARMACAPS) APPROVAL= - YEAR= 0 DISCONTINUED |
Other links: |